[Form 4] IonQ, Inc. Insider Trading Activity
Thomas G. Kramer, Chief Financial Officer of IonQ, Inc. reported the sale of 537,880 shares of common stock on 08/06/2025 pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025. The reported weighted average sale price was $41.2804, with individual trades ranging from $40.88 to $43.00. Following these transactions, the reporting person beneficially owns 17,776 shares directly and 5 shares indirectly through a child.
The Form 4 discloses the sale activity and includes an undertaking to provide details on the number of shares sold at each price within the disclosed range upon request.
Thomas G. Kramer, Chief Financial Officer di IonQ, Inc., ha comunicato la vendita di 537,880 azioni ordinarie il 6 agosto 2025 in base a un piano di negoziazione Rule 10b5-1 adottato il 14 marzo 2025. Il prezzo medio ponderato riportato è stato di $41.2804, con singole operazioni comprese tra $40.88 e $43.00. Dopo queste transazioni, la persona segnalante detiene beneficiariamente 17,776 azioni direttamente e 5 azioni indirettamente tramite un figlio.
Il modulo Form 4 rende noto l'attività di vendita e include l'impegno a fornire, su richiesta, i dettagli sul numero di azioni vendute a ciascun prezzo all'interno dell'intervallo comunicato.
Thomas G. Kramer, Director Financiero de IonQ, Inc., informó la venta de 537,880 acciones ordinarias el 6 de agosto de 2025 en virtud de un plan de negociación Rule 10b5-1 adoptado el 14 de marzo de 2025. El precio medio ponderado informado fue de $41.2804, con operaciones individuales entre $40.88 y $43.00. Tras estas transacciones, la persona que presenta el informe posee beneficiariamente 17,776 acciones en forma directa y 5 acciones en forma indirecta a través de un hijo.
El Formulario 4 divulga la actividad de venta e incluye el compromiso de proporcionar, a solicitud, detalles sobre el número de acciones vendidas a cada precio dentro del rango divulgado.
Thomas G. Kramer은(�) IonQ, Inc.� 최고재무책임자로� 2025� 8� 6�� 537,880주의 보통주를 2025� 3� 14�� 채택� Rule 10b5-1 거래계획� 따라 매도했다� 보고했습니다. 보고� 가중평� 매도가격은 $41.2804였으며, 개별 거래� $40.88에서 $43.00 사이였습니�. � 거래� 이후 보고인은 직접적으� 17,776주를 실질 보유하고 있으�, 자녀� 통해 간접적으� 5주를 보유하고 있습니다.
Form 4� 매도 내역� 공개하며, 공개� 범위 � � 가격대에서 매도� 주식 수에 대� 세부사항� 요청 � 제공하겠다는 약속� 포함하고 있습니다.
Thomas G. Kramer, directeur financier d'IonQ, Inc., a déclaré la vente de 537,880 actions ordinaires le 6 août 2025 en vertu d'un plan de négociation Rule 10b5-1 adopté le 14 mars 2025. Le prix de vente moyen pondéré déclaré était de $41.2804, avec des transactions individuelles allant de $40.88 à $43.00. À la suite de ces opérations, la personne déclarante possède à titre bénéficiaire 17,776 actions directement et 5 actions indirectement par l'intermédiaire d'un enfant.
Le formulaire Form 4 divulgue l'activité de vente et inclut l'engagement de fournir, sur demande, les détails du nombre d'actions vendues à chaque prix dans la fourchette divulguée.
Thomas G. Kramer, Chief Financial Officer von IonQ, Inc., meldete den Verkauf von 537,880 Stammaktien am 6. August 2025 gemäß einem Rule�10b5�1‑Handelsplan, der am 14. März 2025 angenommen wurde. Der gemeldete gewichtete Durchschnittspreis betrug $41.2804, wobei einzelne Transaktionen zwischen $40.88 und $43.00 lagen. Nach diesen Transaktionen besitzt die meldende Person wirtschaftlich 17,776 Aktien direkt und 5 Aktien indirekt über ein Kind.
Das Formular Form 4 legt die Verkaufsaktivität offen und enthält die Zusage, auf Anfrage Einzelheiten zur Anzahl der zu jedem Preis innerhalb der angegebenen Spanne verkauften Aktien zu liefern.
- Transaction executed under a Rule 10b5-1 trading plan, indicating pre-established trading instructions
- Weighted average price and full trade range disclosed ($41.2804 weighted avg; $40.88�$43.00 range), enhancing transparency
- Reporting person offers to provide per-trade allocation details upon request
- Large insider sale reported: 537,880 shares were sold, which may be viewed as significant by some investors
- Substantial reduction in direct holdings: beneficial ownership after the sale is shown as 17,776 shares
Insights
TL;DR: Large officer sale disclosed under a 10b5-1 plan; transparent pricing range provided.
The report shows that IonQ's CFO executed a planned sale of 537,880 shares under a Rule 10b5-1 trading plan adopted March 14, 2025, at a reported weighted average of $41.2804 and an execution price range of $40.88�$43.00. The filing states the reporting person retains 17,776 shares directly and 5 shares indirectly. From an analytics perspective, this is a clear disclosure of insider liquidity rather than an operational or financial performance update. The filing includes an explicit offer to provide per-price allocation details, which supports transparency for investors or regulators requesting granularity.
TL;DR: Insider sale followed a documented 10b5-1 plan, showing procedural compliance and added transparency.
The Form 4 indicates the sale was executed pursuant to a Rule 10b5-1 plan, which is a commonly used mechanism for pre-scheduled insider transactions. The footnote discloses the plan adoption date and provides a weighted average price plus the full trade price range ($40.88�$43.00), and the reporting person commits to furnish per-trade counts on request. These elements reflect adherence to routine disclosure and documentation practices under Section 16 reporting obligations. The filing does not include any additional corporate governance actions or changes in role.
Thomas G. Kramer, Chief Financial Officer di IonQ, Inc., ha comunicato la vendita di 537,880 azioni ordinarie il 6 agosto 2025 in base a un piano di negoziazione Rule 10b5-1 adottato il 14 marzo 2025. Il prezzo medio ponderato riportato è stato di $41.2804, con singole operazioni comprese tra $40.88 e $43.00. Dopo queste transazioni, la persona segnalante detiene beneficiariamente 17,776 azioni direttamente e 5 azioni indirettamente tramite un figlio.
Il modulo Form 4 rende noto l'attività di vendita e include l'impegno a fornire, su richiesta, i dettagli sul numero di azioni vendute a ciascun prezzo all'interno dell'intervallo comunicato.
Thomas G. Kramer, Director Financiero de IonQ, Inc., informó la venta de 537,880 acciones ordinarias el 6 de agosto de 2025 en virtud de un plan de negociación Rule 10b5-1 adoptado el 14 de marzo de 2025. El precio medio ponderado informado fue de $41.2804, con operaciones individuales entre $40.88 y $43.00. Tras estas transacciones, la persona que presenta el informe posee beneficiariamente 17,776 acciones en forma directa y 5 acciones en forma indirecta a través de un hijo.
El Formulario 4 divulga la actividad de venta e incluye el compromiso de proporcionar, a solicitud, detalles sobre el número de acciones vendidas a cada precio dentro del rango divulgado.
Thomas G. Kramer은(�) IonQ, Inc.� 최고재무책임자로� 2025� 8� 6�� 537,880주의 보통주를 2025� 3� 14�� 채택� Rule 10b5-1 거래계획� 따라 매도했다� 보고했습니다. 보고� 가중평� 매도가격은 $41.2804였으며, 개별 거래� $40.88에서 $43.00 사이였습니�. � 거래� 이후 보고인은 직접적으� 17,776주를 실질 보유하고 있으�, 자녀� 통해 간접적으� 5주를 보유하고 있습니다.
Form 4� 매도 내역� 공개하며, 공개� 범위 � � 가격대에서 매도� 주식 수에 대� 세부사항� 요청 � 제공하겠다는 약속� 포함하고 있습니다.
Thomas G. Kramer, directeur financier d'IonQ, Inc., a déclaré la vente de 537,880 actions ordinaires le 6 août 2025 en vertu d'un plan de négociation Rule 10b5-1 adopté le 14 mars 2025. Le prix de vente moyen pondéré déclaré était de $41.2804, avec des transactions individuelles allant de $40.88 à $43.00. À la suite de ces opérations, la personne déclarante possède à titre bénéficiaire 17,776 actions directement et 5 actions indirectement par l'intermédiaire d'un enfant.
Le formulaire Form 4 divulgue l'activité de vente et inclut l'engagement de fournir, sur demande, les détails du nombre d'actions vendues à chaque prix dans la fourchette divulguée.
Thomas G. Kramer, Chief Financial Officer von IonQ, Inc., meldete den Verkauf von 537,880 Stammaktien am 6. August 2025 gemäß einem Rule�10b5�1‑Handelsplan, der am 14. März 2025 angenommen wurde. Der gemeldete gewichtete Durchschnittspreis betrug $41.2804, wobei einzelne Transaktionen zwischen $40.88 und $43.00 lagen. Nach diesen Transaktionen besitzt die meldende Person wirtschaftlich 17,776 Aktien direkt und 5 Aktien indirekt über ein Kind.
Das Formular Form 4 legt die Verkaufsaktivität offen und enthält die Zusage, auf Anfrage Einzelheiten zur Anzahl der zu jedem Preis innerhalb der angegebenen Spanne verkauften Aktien zu liefern.